Hematologic Oncology Update

By: Dr Neil Love
Listen for free

  • Summary

  • Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
    Copyright 2008 Research To Practice. All Rights Reserved
    Show More Show Less
Science
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma

    What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
    Dec 21 2024
    Prof Philippe Moreau of University Hospital – CHU de Nantes in France, Dr Robert Z Orlowski of The University of Texas MD Anderson Cancer Center in Houston, Dr Noopur Raje of Massachusetts General Hospital Cancer Center in Boston, Dr Paul G Richardson of Dana-Farber Cancer Institute in Boston, and Dr Sagar Lonial of Winship Cancer Institute of Emory University in Atlanta, Georgia, discuss current questions and controversies in the management of multiple myeloma.
    Show More Show Less
    1 hr and 57 mins
  • What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

    What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
    Dec 19 2024
    Dr Farrukh Awan from Harold C Simmons Comprehensive Cancer Center in Dallas, Texas, Dr Bita Fakhri from Stanford University School of Medicine in California, Dr Kerry A Rogers from the Ohio State University in Columbus, Dr William Wierda from the University of Texas MD Anderson Cancer Center in Houston, and moderator Dr Jeff Sharman from the Sarah Cannon Research Institute discuss updated data from ASH 2024 influencing the current and future treatment paradigm for treatment-naïve and relapsed/refractory chronic lymphocytic leukemia.
    Show More Show Less
    1 hr and 57 mins

What listeners say about Hematologic Oncology Update

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available